------------------------DOSAGE AND ADMINISTRATION---------------------Rheumatoid Arthritis  Recommended dose of XELJANZ is 5 mg twice daily. (2.1)  Moderate and severe renal impairment and moderate hepatic impairme

First Page		Document Content
Date: 2015-06-22 13:44:18 Medicine Clinical medicine Immunosuppressants Tuberculosis Tofacitinib Azathioprine Tuberculosis management Latent tuberculosis Anakinra Alefacept		------------------------DOSAGE AND ADMINISTRATION---------------------Rheumatoid Arthritis  Recommended dose of XELJANZ is 5 mg twice daily. (2.1)  Moderate and severe renal impairment and moderate hepatic impairme Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 584,71 KB Share Document on Facebook

	Oragnic Cellular Abstract DocID: 1qFEH - View Document
	AZATHIOPRINE / 6-MERCAPTOPURINE TREATMENT FOR IBD PATIENTS INFORMATION SHEET This information leaflet is designed to answer common questions patients ask about their medicine. Further information can be found in the in DocID: 1qAnH - View Document
	------------------------DOSAGE AND ADMINISTRATION---------------------Rheumatoid Arthritis  Recommended dose of XELJANZ is 5 mg twice daily. (2.1)  Moderate and severe renal impairment and moderate hepatic impairme DocID: 1m0Le - View Document
	In renal transplant patients at high-immunologic risk • Rapamune and Cyclosporine Combination Therapy (for the first 12 months post-transplantation): One loading dose of up to 15 mg on day 1, followed by daily mainten DocID: 1lhSD - View Document
	NEDERLANDS TIJDSCHRIFT VOOR DERMATOLOGIE EN VENEREOLOGIE \| VOLUME 24 \| NUMMER 05 \| meiSamenvatting Azathioprine wordt regelmatig voorgeschreven als tweede keuze oraal immunosuppressivum bij de behandeling van erns DocID: 1dYbe - View Document